Cipralex® /Lexapro® is for the treatment of brain diseases, including major depressive episodes and anxiety. To support the cascade of the Cipralex® /Lexapro® communication strategy to global and local Key Opinion Leaders (KOL), W was asked to develop and implement series of ‘train the trainer’ workshops focusing on delivering effective presentations.
W developed a ½ day workshop to train KOLs on communicating the key Cipralex® /Lexapro® clinical data in a compelling and convincing manner using PowerPoint. After presentations on the Cipralex®/Lexapro® clinical data, and how to deliver an effective presentation / address difficult questions, the KOLs were then asked to construct their own short Cipralex® /Lexapro® presentation, which were then presented to the workshop attendees. W then evaluated the presentations and provided feedback that was shared with the presenter and attendees.
A highly motivating ‘train the trainer’ workshop that created an opportunity for KOLs in the area of psychiatry to refine and develop their presentation skills when presenting the Cipralex® /Lexapro® clinical data, potentially leading to increased understanding and retention of the brand’s key clinical data.
Channels
